Covered recipient · General Payments record
TROY D SCHMIDT
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$4,438.86
- Reported across 266 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $432.00 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $308.54 | 17 |
| Celgene Corporation | $103.58 | 1 |
| Lilly USA, LLC | $19.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.52 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037132 | CMS |
| ABBVIE INC. | $20.31 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037134 | CMS |
| ABBVIE INC. | $17.81 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037136 | CMS |
| ABBVIE INC. | $20.91 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037138 | CMS |
| ABBVIE INC. | $15.46 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037140 | CMS |
| ABBVIE INC. | $25.17 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037142 | CMS |
| ABBVIE INC. | $24.28 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037144 | CMS |
| ABBVIE INC. | $13.65 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037146 | CMS |
| ABBVIE INC. | $22.53 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037148 | CMS |
| ABBVIE INC. | $16.14 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037150 | CMS |
| ABBVIE INC. | $14.65 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037152 | CMS |
| ABBVIE INC. | $21.58 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037154 | CMS |
| ABBVIE INC. | $8.02 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037156 | CMS |
| ABBVIE INC. | $19.49 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037158 | CMS |
| ABBVIE INC. | $14.53 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037160 | CMS |
| ABBVIE INC. | $15.14 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037162 | CMS |
| ABBVIE INC. | $17.35 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106037164 | CMS |
| Celgene Corporation | $103.58 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101144209 | CMS |
| Lilly USA, LLC | $19.88 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135485557 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.